Viewing nowJW Pioglitazone Tablet 30mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

MFDS item code 202002026 · Approved 2020.03.23
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to dietary and exercise therapy to improve blood sugar control in patients with type 2 diabetes. It can be used alone but is often combined with sulfonylureas, metformin, or insulin if the blood sugar improvement effect is inadequate with other hypoglycemic agents. Patients with type 2 diabetes should also undergo nutritional counseling and, if necessary, weight loss, while maintaining a regular exercise regimen. Such lifestyle changes can significantly enhance the initial treatment and sustain the effects of drug therapy. Therefore, this medication is effectively used to improve blood sugar control.
This medicine is administered orally once daily, regardless of meals. Clinically, this medicine should be administered for an appropriate period (at least 3 months) to assess changes in glycated hemoglobin in patients with diabetes, provided that glycemic control does not worsen. 1. Monotherapy This medicine may be initiated as monotherapy at 15 mg of pioglitazone once daily in patients whose blood glucose is not adequately controlled by diet and exercise. If the initial dose of this medicine does not provide an adequate effect, the dose may be increased to a maximum of 30 mg once daily. 2. Combination therapy 1) Sulfonylureas: This medicine may be administered in combination with a sulfonylurea. The initial dose is 15 mg once daily. When this medicine is used in combination therapy, the current sulfonylurea may be continued at the same dose and schedule. However, if the patient develops symptoms of hypoglycemia, the sulfonylurea dose should be reduced. 2) Metformin: This medicine may be administered in combination with metformin. The initial dose is 15 mg once daily. When this medicine is used in combination therapy, the current metformin may be continued at the same dose and schedule. 3) Insulin: This medicine may be administered in combination with insulin at a dose of 15 mg once daily. The current insulin dose may be maintained when combination therapy with this medicine is initiated. However, in patients receiving this medicine in combination with insulin, the insulin dose may be reduced by 10 ~ 25 % if symptoms of hypoglycemia occur or plasma glucose falls to 100 mg/dL or below. Subsequent dose adjustments should be individualized according to glycemic control. • Maximum recommended dose For monotherapy or combination therapy with a sulfonylurea, metformin, or insulin, doses exceeding 30 mg once daily are not recommended.
Children under 18 years: Use is not recommended because there is no experience with its use.
This medication is used for the treatment of type 2 diabetes and acts to lower blood sugar levels in conjunction with insulin. This medication may put a strain on the heart, so it should not be used in patients with heart failure or a history of heart failure. After starting treatment or increasing the dosage, it is crucial to monitor closely for symptoms of heart failure, such as rapid weight gain, shortness of breath, or swelling. If any of these symptoms appear, consult a doctor immediately for appropriate treatment, as dosage adjustments or discontinuation of this medication may be necessary. This medication can cause fluid retention, worsening edema or heart failure, so it should be used cautiously in patients with edema or cardiovascular disease. Additionally, if symptoms associated with bladder cancer, such as hematuria or urination disorders, occur, inform a doctor immediately, and this medication should not be used in patients with a history of bladder cancer or active bladder cancer. Patients with impaired liver function also need to be cautious when using this medication, and the decision to use it should depend on liver function test results. The risk of hypoglycemia may increase when this medication is used in combination with insulin or other hypoglycemic agents, so patients should be adequately educated about hypoglycemia symptoms and their management. For premenopausal women, this medication may induce ovulation, increasing the risk of pregnancy, so appropriate contraceptive methods should be employed. Elderly patients or those with impaired kidney function should also exercise caution when using this medication, and regular monitoring of blood sugar and liver function is recommended. During treatment with this medication, if sudden weight gain, edema, or shortness of breath occurs, consult healthcare personnel immediately. Drug interactions may occur, so if other medications are being taken, inform a physician or pharmacist, especially when used with specific enzymes that inhibit or induce liver function, as dosage adjustments may be necessary. Women who are pregnant or may become pregnant, as well as nursing mothers, should consult a doctor before using this medication, as data on safety are limited. In the case of overdose, specific symptoms may not manifest, but appropriate treatment should be administered based on clinical symptoms. This medication is not used in children as safety and efficacy have not been established.
Congestive heart failure, excessive and rapid weight change, shortness of breath, edema, fluid retention, swelling, upper respiratory tract infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular factors, worsening of congestive heart failure, emergency room visits due to congestive heart failure, cardiovascular abnormalities, liver failure, diabetic macular edema with vision reduction, elevated serum ALT levels, decreased hemoglobin, elevated serum creatine kinase, bladder cancer, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle rigidity, discomfort in the head, increased liver enzymes, worsening of liver disease, urticaria, eczema, joint pain, knee abnormalities, arm weakness syndrome, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, weight gain, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that prevents light and air from entering, and precautions should be taken to avoid moisture. The storage temperature should be around 25 degrees Celsius, but it is best stored at a temperature between 15 and 30 degrees Celsius.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.